Delivery Order SPE2DB20D2104-SPE2DB23FT69B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,477.40 Firm Fixed Price Delivery Order contract is for the supply of 4566374240 CEVIMELINE HCL 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,846.76 firm fixed-price delivery order is for the supply of 4,557,876,692 capsules of the drug cevimeline hydrochloride, a medication used to treat dry mouth. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE7GM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.03 firm fixed-price delivery order is for the provision of 4562519587 - CEVIMELINE HCL 30 MG CAPSULE 100S, a generic pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.98, is for the delivery of 4560957209 - CEVIMELINE HCL 30 MG CAPSULE 100S. This is a Firm Fixed Price Delivery Order contract with a completion date of May 17, 2023. The contract is not designated as a set-aside. AmerisourceBergen maintains a significant Indefinite...
- This federal contract award is for the delivery of CEVIMELINE HCL 30 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 20, 2023, with a ceiling value of $1,023.15 and a completion date of December 21, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,477.62 firm fixed-price delivery order is for the provision of 4,566,248,894 units of a 6,000 unit capsule product, with a period of performance through October 29, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $135,483.16 firm fixed-price delivery order has a completion date of December 14, 2023 and is not designated as a set-aside contract. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide pharmaceutical products and medical supplies as a prime vendor. The contract has a ceiling value of $3,210.15 and runs through August 27, 2020. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for a delivery order with a ceiling value of $26,160.15, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans'...
- This federal contract award from the Defense Logistics Agency (DLA) is for pharmaceutical and medical supplies to support military and veterans' healthcare programs. The $21,491.10 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 23, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT69BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4561055140 Cevimeline HCL 30 mg capsules. The $3,630.50 firm fixed-price delivery order (SPE2DB23FT69B) has a completion date of May 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/25/23 |